News|Articles|November 20, 2023
Data is Becoming a Differentiator for Hubs that Support Specialty Drugs
Author(s)CareMetx
In a recent study, CareMetx engaged with senior leadership at leading biopharmaceutical manufacturers, aiming to evaluate the optimal ways in which Hub data can enhance manufacturer support. These findings can serve as a valuable guide for manufacturers seeking insights on optimizing their utilization of Hub data.
Advertisement
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
3
A 'Beautiful Fake': Pharma Fraudsters Upping Their Game
4
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
5
